




Instance: composition-en-6717e3b12c817674be9c520895f4090e
InstanceOf: CompositionUvEpi
Title: "Composition for competact Package Leaflet"
Description:  "Composition for competact Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/06/354/005"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp6717e3b12c817674be9c520895f4090e)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - competact"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  
  </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet:</p>
<ol type="1">
<li>What Competact is and what it is used for</li>
<li>What you need to know before you take Competact</li>
<li>How to take Competact</li>
<li>Possible side effects</li>
<li>How to store Competact</li>
<li>Contents of the pack and other information</li>
</ol>
 </div>"""   
          

* section[=].section[+]
  * title =  "1. What competact is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What competact is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Competact contains pioglitazone and metformin. It is an anti-diabetic
medicine used in adults to treat type 2 (non-insulin dependent) diabetes
mellitus when treatment with metformin alone is not sufficient. This
type 2 diabetes usually develops in adulthood particularly as a result
of the person being overweight and where the body either does not
produce enough insulin (a hormone that controls blood sugar levels), or
cannot effectively use the insulin it produces. Your doctor will check
whether Competact is working 3 to 6 months after you start taking
it.</p>
<p>Competact helps control the level of sugar in your blood when you
have type 2 diabetes by helping your body make better use of the insulin
it produces.</p>
 </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take competact"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take competact"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Competact</p>
<ul>
<li>if you are allergic to pioglitazone, metformin or any of the other
ingredients of this medicine (listed in section 6).</li>
<li>if you have heart failure or have had heart failure in the
past.</li>
<li>if you recently had a heart attack, have severe circulatory problems
including shock, or breathing difficulties.</li>
<li>if you have liver disease.</li>
<li>if you drink alcohol excessively (either every day or only from time
to time).</li>
<li>if you have uncontrolled diabetes, with for example severe
hyperglycaemia (high blood glucose), nausea, vomiting, diarrhoea, rapid
weight loss, lactic acidosis (see section Risk of lactic acidosis ) or
ketoacidosis. Ketoacidosis is a condition in which substances called
'ketone bodies' accumulate in the blood and which can lead to diabetic
pre-coma. Symptoms include stomach pain, fast and deep breathing,
sleepiness or your breath developing an unusual fruity smell.</li>
<li>if you have or have ever had bladder cancer.</li>
<li>if you have blood in your urine that your doctor has not
checked.</li>
<li>if you have severely reduced kidney function.</li>
<li>if you have a severe infection or are dehydrated.</li>
<li>if you are going to have a certain type of X-ray with an injectable
dye, talk to your doctor as you must stop taking Competact for a certain
period of time before and after the examination.</li>
<li>if you are breast-feeding.</li>
</ul>
<p>Warnings and precautions Talk to your doctor or pharmacist before
taking Competact (see also section 4).</p>
<ul>
<li>if you have a problem with your heart. Some patients with
long-standing type 2 diabetes mellitus and heart disease or previous
stroke who were treated with pioglitazone and insulin together
experienced the development of heart failure. Inform your doctor as soon
as possible if you experience signs of heart failure such as unusual
shortness of breath or rapid increase in weight or localised swelling
(oedema).</li>
<li>if you retain water (fluid retention) or have heart failure problems
in particular if you are over 75 years old. If you take
anti-inflammatory medicines which can also cause fluid retention and
swelling, you must also tell your doctor.</li>
<li>if you have a special type of diabetic eye disease called macular
oedema (swelling of the back of the eye), talk to your doctor if you
notice any change to your vision.</li>
<li>if you have cysts on your ovaries (polycystic ovary syndrome). There
may be an increased possibility of becoming pregnant because you may
ovulate again when you take Competact. If this applies to you, use
appropriate contraception to avoid the possibility of an unplanned
pregnancy.</li>
<li>if you have a problem with your liver. Before you start taking
Competact you will have a blood sample taken to check your liver
function. This check should be repeated at intervals. Inform your doctor
as soon as possible if you develop symptoms suggesting a problem with
your liver (like feeling sick without explanations, vomiting, stomach
ache, tiredness, loss of appetite and/or dark urine) as your liver
function should be checked.</li>
</ul>
<p>You may also experience a reduction in blood count (anaemia).</p>
<p>Risk of lactic acidosis Competact may cause a very rare, but very
serious side effect called lactic acidosis, particularly if your kidneys
are not working properly. The risk of developing lactic acidosis is also
increased with uncontrolled diabetes, serious infections, prolonged
fasting or alcohol intake, dehydration (see further information below),
liver problems and any medical conditions in which a part of the body
has a reduced supply of oxygen (such as acute severe heart
disease).<br />
If any of the above apply to you, talk to your doctor for further
instructions.</p>
<p>Stop taking Competact for a short time if you have a condition that
may be associated with dehydration (significant loss of body fluids)
such as severe vomiting, diarrhoea, fever, exposure to heat or if you
drink less fluid than normal. Talk to your doctor for further
instructions.</p>
<p>Stop taking Competact and contact a doctor or the nearest hospital
immediately if you experience some of the symptoms of lactic acidosis,
as this condition may lead to coma.<br />
Symptoms of lactic acidosis include:</p>
<ul>
<li>vomiting</li>
<li>stomach ache (abdominal pain)</li>
<li>muscle cramps</li>
<li>a general feeling of not being well with severe tiredness</li>
<li>difficulty in breathing</li>
<li>reduced body temperature and heartbeat</li>
</ul>
<p>Lactic acidosis is a medical emergency and must be treated in a
hospital.</p>
<p>During treatment with Competact, your doctor will check your kidney
function at least once a year or more frequently if you are elderly
and/or if you have worsening kidney function.</p>
<p>If you need to have major surgery you must stop taking Competact
during and for some time after the procedure. Your doctor will decide
when you must stop and when to restart your treatment with
Competact.</p>
<p>Hypoglycaemia If you take Competact with other medicines for
diabetes, it is more likely that your blood sugar could fall below the
normal level (hypoglycaemia). If you experience symptoms of
hypoglycaemia such as weakness, dizziness, increased sweating, fast
heart-beating, vision disorders or difficulty in concentration, you
should take some sugar to increase your blood sugar level again. Ask
your doctor or pharmacist for more information if you are not sure how
to recognise this. It is recommended that you carry some sugar lumps,
sweets, biscuits or sugary fruit juice</p>
<p>Broken bones A higher number of bone fractures was seen in patients,
particularly women taking pioglitazone. Your doctor will take this into
account when treating your diabetes.</p>
<p>Children and adolescents Use in children and adolescents under 18
years is not recommended.</p>
<p>Other medicines and Competact If you need to have an injection of a
contrast medium that contains iodine into your bloodstream, for example
in the context of an X-ray or scan, you must stop taking Competact
before or at the time of the injection. Your doctor will decide when you
must stop and when to restart your treatment with Competact.</p>
<p>Tell your doctor or pharmacist if you are taking, have recently taken
or might take any other medicines. You may need more frequent blood
glucose and kidney function tests, or your doctor may need to adjust the
dose of Competact. It is especially important to mention the
following:</p>
<ul>
<li>gemfibrozil (used to lower cholesterol)</li>
<li>rifampicin (used to treat tuberculosis and other infections)</li>
<li>cimetidine (used to reduce stomach acid)</li>
<li>glucocorticoids (used to treat inflammation)</li>
<li>beta-2-agonists (used to treat asthma)</li>
<li>medicines which increase urine production (diuretics)</li>
<li>medicines used to treat pain and inflammation (NSAID and
COX-2-inhibitors, such as ibuprofen and celecoxib)</li>
<li>certain medicines for the treatment of high blood pressure
(angiotensin-converting enzyme (ACE) inhibitors and angiotensin II
receptor antagonists)</li>
</ul>
<p>Competact with alcohol Avoid excessive alcohol intake while taking
Competact since this may increase the risk of lactic acidosis (see
section Risk of lactic acidosis ).</p>
<p>Pregnancy and breast-feeding</p>
<ul>
<li>you must tell your doctor if you are pregnant, think you may be
pregnant or are planning to have a baby. Competact is not recommended in
pregnancy. If you wish to become pregnant, your doctor will advise you
to discontinue this medicine.</li>
<li>do not use Competact if you are breastfeeding or are planning to
breast-feed (see section Do not take Competact ).</li>
</ul>
<p>Driving and using machines This medicine will not affect your ability
to drive or use machines but take care if you experience abnormal
vision.</p>
<p>Competact contains sodium This medicine contains less than 1 mmol
sodium (23 mg) per tablet, that is to say essentially sodium-free .</p>
 </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take competact"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take competact"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor or pharmacist has
told you. Check with your doctor or pharmacist if you are not sure.</p>
<p>The recommended dose is one tablet taken twice daily. If necessary
your doctor may tell you to take a different dose. If you have reduced
kidney function, your doctor may prescribe a lower dose, which may need
to be given as separate tablets of pioglitazone and metformin.</p>
<p>You should swallow the tablets with a glass of water. You may take
your tablets with or just after food to reduce the chance of an upset
stomach.</p>
<p>If you are following a special diet for diabetes, you should continue
with this while you are taking Competact.</p>
<p>Your weight should be checked at regular intervals; if your weight
increases, inform your doctor.</p>
<p>Your doctor will ask you to have blood tests periodically during
treatment with Competact. This is to check that your liver is working
normally. At least once a year (more often if you are elderly or have
kidney problems) your doctor will check that your kidneys are working
normally.</p>
<p>If you take more Competact than you should If you accidentally take
too many tablets, or if someone else or a child takes your medicine,
talk to a doctor or pharmacist immediately. Your blood sugar could fall
below the normal level and can be increased by taking sugar. It is
recommended that you carry some sugar lumps, sweets, biscuits or sugary
fruit juice. If you have taken more Competact that you should have, you
may experience lactic acidosis (see section Risk of lactic acidosis
).</p>
<p>If you forget to take Competact Take Competact daily as prescribed.
However if you miss a dose, skip the missed dose and just carry on with
the next dose as normal. Do not take a double dose to make up for a
forgotten tablet.</p>
<p>If you stop taking Competact Competact should be used every day to
work properly. If you stop using Competact, your blood sugar may go up.
Talk to your doctor before stopping this treatment.</p>
<p>If you have any further questions on the use of this medicine ask
your doctor or pharmacist.</p>
 </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although
not everybody gets them.</p>
<p>Competact may cause a very rare (may affect up to 1 in 10,000), but
very serious side effect called lactic acidosis (see section Risk of
lactic acidosis ). If this happens you must stop taking Competact and
contact a doctor or the nearest hospital immediately, as lactic acidosis
may lead to coma.</p>
<p>Bladder cancer has been experienced uncommonly (may affect up to 1 in
100 people) in patients taking Competact. Signs and symptoms include
blood in your urine, pain when urinating or a sudden need to urinate. If
you experience any of these, talk to your doctor as soon as
possible.</p>
<p>Broken bones have been reported commonly (may affect up to 1 in 10
people) in female patients taking Competact and have also been reported
in male patients (frequency cannot be estimated from the available data)
taking Competact. If you experience this side effect, talk to your
doctor as soon as possible.</p>
<p>Blurred vision due to swelling (or fluid) at the back of the eye
(macular oedema) has been reported (frequency cannot be estimated from
available data). If you experience these symptoms for the first time
talk to your doctor as soon as possible. Also, if you already have
blurred vision and the symptoms get worse, talk to your doctor as soon
as possible.</p>
<p>Allergic reactions have been reported with frequency not known
(cannot be estimated from available data) in patients taking Competact.
If you have a serious allergic reaction, including hives and swelling of
the face, lips, tongue, or throat that may cause difficulty in breathing
or swallowing, stop taking this medicine and talk to your doctor
immediately.</p>
<p>The following side effects have been experienced by some patients
taking Competact:</p>
<p>Very common (may affect more than 1 in 10 people)</p>
<ul>
<li>stomach ache</li>
<li>feeling sick (nausea)</li>
<li>vomiting</li>
<li>diarrhoea</li>
<li>loss of appetite</li>
</ul>
<p>Common (may affect up to 1 in 10 people)</p>
<ul>
<li>localised swelling (oedema)</li>
<li>weight gain</li>
<li>headache</li>
<li>respiratory infection</li>
<li>abnormal vision</li>
<li>joint pain</li>
<li>impotence</li>
<li>blood in urine</li>
<li>reduction in blood count (anaemia)</li>
<li>numbness</li>
<li>taste disturbance</li>
</ul>
<p>Uncommon (may affect up to 1 in 100 people)</p>
<ul>
<li>inflammation of the sinuses (sinusitis)</li>
<li>gas</li>
<li>difficulty sleeping (insomnia)</li>
</ul>
<p>Very rare (may affect up to 1 in 10,000)</p>
<ul>
<li>decrease in amount of vitamin B12 in the blood</li>
<li>redness of the skin</li>
<li>itchy skin</li>
<li>raised and itchy rash (hives)</li>
</ul>
<p>Not known (frequency can not be estimated from the available
data)</p>
<ul>
<li>inflammation of the liver (hepatitis)</li>
<li>liver does not work as well as it should (changes in liver
enzymes)</li>
</ul>
<p>Reporting of side effects If you get any side effects, talk to your
doctor or pharmacist. This includes any possible side effects not listed
in this leaflet. You can also report side effects directly via the
national reporting system listed in Appendix V. By reporting side
effects you can help provide more information on the safety of this
medicine.</p>
 </div>"""      
        
* section[=].section[+]
  * title = "5. How to store competact"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store competact"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children.</p>
<p>Do not use this medicine after the expiry date which is stated on the
carton and the blister after EXP . The expiry date refers to the last
day of that month.</p>
<p>This medicine does not require any special storage conditions.</p>
<p>Do not throw away any medicines via wastewater or household waste.
Ask your pharmacist how to throw away medicines you no longer use. These
measures will help protect the environment.</p>
 </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Competact contains</p>
<ul>
<li>The active substances are pioglitazone and metformin hydrochloride.
Each tablet contains 15 mg pioglitazone (as hydrochloride) and 850 mg
metformin hydrochloride.</li>
<li>The other ingredients are microcrystalline cellulose, povidone
(K30), croscarmellose sodium</li>
</ul>
<p>magnesium stearate, hypromellose, macrogol 8000, talc and titanium
dioxide (E171).</p>
<p>What Competact looks like and contents of the pack The film-coated
tablets (tablets) are white to off white, oblong, convex, embossed 15 /
850 on one face and 4833M on the other. They are supplied in
aluminium/aluminium blisters in packs of 56 and 112 tablets.</p>
<p>Not all pack sizes may be marketed.</p>
<p>Marketing authorisation holder CHEPLAPHARM Arzneimittel GmbH
Ziegelhof 17489 Greifswald Germany</p>
<p>Manufacturer Takeda Ireland Limited, Bray Business Park, Kilruddery,
County Wicklow, Ireland Delpharm Novara S.r.l., Via Crosa, 86, I-28065
Cerano (NO), Italy Lilly S.A., Avda. de la Industria 30, 28108
Alcobendas, Madrid, Spain</p>
<p>This leaflet was last revised in August 2023. Other sources of
information</p>
<p>Detailed information on this medicine is available on the European
Medicines Agency website <a
href="http://www.ema.europa.eu">http://www.ema.europa.eu</a>.</p>
 </div>"""      



Instance: composition-da-6717e3b12c817674be9c520895f4090e
InstanceOf: CompositionUvEpi
Title: "Composition for competact Package Leaflet"
Description:  "Composition for competact Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/06/354/005"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp6717e3b12c817674be9c520895f4090e)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - competact"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. INDLÆGSSEDDEL"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. INDLÆGSSEDDEL"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Indlægsseddel: Information til brugeren"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Indlægsseddel: Information til brugeren"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Se den nyeste indlægsseddel på <a
href="http://www.indlaegsseddel.dk">www.indlaegsseddel.dk</a></p>
  </div>"""   



* section[=].section[+]
  * title = "Oversigt over indlægssedlen"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Oversigt over indlægssedlen"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen</p>
<ol type="1">
<li>Virkning og anvendelse</li>
<li>Det skal De vide, før De begynder at tage Competact</li>
<li>Sådan skal De tage Competact</li>
<li>Bivirkninger</li>
<li>Opbevaring</li>
<li>Pakningsstørrelser og yderligere oplysninger</li>
</ol>
 </div>"""   
          

* section[=].section[+]
  * title =  "1. Virkning og anvendelse"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. Virkning og anvendelse"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Competact indeholder pioglitazon og metformin. Det er medicin mod
sukkersyge og anvendes til behandling af type 2 (ikke-insulinkrævende)
diabetes mellitus hos voksne, hvor behandling med metformin alene ikke
er tilstrækkelig. Type 2 er en diabetesform, der normalt udvikler sig i
voksenalderen, især hvis personen er overvægtig. Kroppen producerer ikke
tilstrækkeligt insulin (et hormon, som kontrollerer blodsukkerniveauet),
eller kroppen udnytter ikke den insulin, den producerer, tilstrækkeligt
effektivt. Når De har taget Competact i 3-6 måneder, vil Deres læge
undersøge, om medicinen virker.</p>
<p>Når De har type 2-diabetes, hjælper Competact Deres krop med bedre at
udnytte den insulin, kroppen producerer. Dermed hjælper Competact med
til at kontrollere sukkerniveauet i Deres blod.</p>
 </div>"""   
          

             
* section[=].section[+]
  * title = "2. Det skal du vide, før du begynder at tage  competact"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. Det skal du vide, før du begynder at tage  competact"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Competact</p>
<ul>
<li>hvis De er allergisk over for pioglitazon, metformin eller et af de
øvrige indholdsstoffer i dette lægemiddel (angivet i punkt 6).</li>
<li>hvis De lider af hjertesvigt eller tidligere har haft
hjertesvigt.</li>
<li>hvis De for nyligt har haft et hjertetilfælde, eller har haft
alvorlige kredsløbsproblemer, herunder chok og
vejrtrækningsproblemer.</li>
<li>hvis De har en leversygdom.</li>
<li>hvis De har et overdrevent alkoholforbrug (enten hver dag eller fra
tid til anden).</li>
<li>Hvis du har dårligt kontrolleret diabetes, der eksempelvis er
ledsaget af alvorlig hyperglykæmi (højt blodsukker), kvalme, opkastning,
diarré, hurtigt vægttab, laktatacidose (se afsnittet "Risiko for
laktatacidose") eller ketoacidose. Ketoacidose er en tilstand, hvor
såkaldte ketonstoffer ophobes i blodet, hvilket kan føre til diabetisk
prækoma. Symptomerne omfatter mavesmerter, hurtig og dyb vejrtrækning og
søvnighed, og din ånde kan få en usædvanlig frugtagtig lugt.</li>
<li>hvis De har eller nogensinde har haft blærekræft.</li>
<li>hvis De har blod i urinen, og Deres læge ikke har undersøgt
årsagen.</li>
<li>Hvis du har alvorligt nedsat nyrefunktion.</li>
<li>hvis De har en alvorlig infektion eller lider af væskemangel.</li>
<li>hvis De skal gennemgå visse typer af røntgenundersøgelser, hvor De
får indsprøjtet kontraststof. Tal med lægen, da De skal holde op med at
tage Competact i en periode før og efter undersøglsen.</li>
<li>hvis De ammer.</li>
</ul>
<p>Advarsler og forsigtighedsregler Kontakt lægen eller
apotekspersonalet, før De tager Competact (se også punkt 4)</p>
<ul>
<li>hvis De har problemer med hjertet. Nogle patienter, som har haft
type 2-diabetes mellitus i mange år og samtidig har hjertesygdom eller
har haft et slagtilfælde, har udviklet hjertesvigt, når de blev
behandlet med pioglitazon og insulin samtidig. Kontakt lægen hurtigst
muligt, hvis De oplever tegn på hjertesvigt såsom usædvanlig åndenød,
hurtig vægtstigning eller lokale væskeansamlinger (ødemer).</li>
<li>hvis De har vand i kroppen (ødemer) eller har problemer med
hjertesvigt, specielt hvis De er over 75 år. Hvis De tager
antiinflammatoriske (betændelseshæmmende) lægemidler, som også kan
forårsage væskeophobning og hævelse, skal De også fortælle det til
lægen.</li>
<li>hvis De lider af en særlig øjenlidelse hos diabetikere, som hedder
makulaødem (væskeansamling i det bagerste af øjet). Tal med lægen, hvis
Deres syn ændrer sig.</li>
<li>hvis De har cyster på æggestokkene (polycystisk ovariesyndrom). Der
kan være større sandsynlighed for at blive gravid, fordi De kan få
ægløsning igen, når De tager Competact. Hvis dette er relevant for Dem,
skal De anvende sikker prævention, så De undgår uønsket graviditet.</li>
<li>hvis De har leverproblemer. Før De begynder at tage Competact, vil
De få taget en blodprøve til kontrol af leverfunktionen. Denne kontrol
bør udføres løbende. Kontakt lægen hurtigst muligt, hvis De får
symptomer, som kan tyde på leverproblemer (såsom uforklarlig kvalme,
opkastning, mavesmerter, træthed, appetitløshed og/eller mørk urin), da
Deres leverfunktion bør tjekkes.</li>
</ul>
<p>De kan også få blodmangel (anæmi).</p>
<p>Risiko for laktatacidose Competact kan forårsage en meget sjælden,
men meget alvorlig bivirkning, som kaldes laktatacidose, især hvis dine
nyrer ikke fungerer korrekt. Risikoen for at udvikle laktatacidose er
også forhøjet ved dårligt kontrolleret diabetes, alvorlige infektioner,
længerevarende faste eller alkoholindtagelse, dehydrering (væskemangel 
se yderligere oplysninger nedenfor), leverproblemer og enhver tilstand
med nedsat iltforsyning til en legemsdel (såsom akut alvorlig
hjertesygdom).<br />
Kontakt lægen for at få yderligere vejledning, hvis noget af ovennævnte
gælder for dig.</p>
<p>Stop med at tage Competact i en kort periode, hvis du har en
tilstand, som kan være forbundet med dehydrering (betydeligt tab af
kropsvæsker), såsom alvorlig opkastning, diarré, feber, udsættelse for
varme eller indtagelse af mindre væske end normalt. Kontakt lægen for at
få yderligere rådgivning.</p>
<p>Stop med at tage Competact og kontakt omgående læge eller nærmeste
hospital, hvis du får et eller flere af nedenstående symptomer på
laktatacidose, da denne tilstand kan føre til koma.<br />
Symptomerne på laktatacidose omfatter:</p>
<ul>
<li>opkastning</li>
<li>mavesmerter</li>
<li>muskelkramper</li>
<li>almen utilpashed med udpræget træthed</li>
<li>vejrtrækningsbesvær</li>
<li>nedsat kropstemperatur og langsommere puls</li>
</ul>
<p>Laktatacidose er en alvorlig tilstand, der skal behandles på et
hospital.</p>
<p>Under behandlingen med Competact vil lægen kontrollere din
nyrefunktion mindst en gang om året eller hyppigere, hvis du er ældre,
og/eller hvis din nyrefunktion bliver dårligere.</p>
<p>Hvis du skal have en større operation, skal du stoppe med at tage
Competact under indgrebet og i nogen tid herefter. Lægen vil beslutte,
hvornår du skal stoppe behandlingen med Competact, og hvornår du kan
genoptage den igen.</p>
<p>Hypoglykæmi Hvis De tager Competact sammen med anden diabetesmedicin,
er der en større risiko for, at Deres blodsukker falder til under det
normale niveau (hypoglykæmi). Hvis de får symptomer på hypoglykæmi som
f.eks. svaghed, svimmelhed, øget svedproduktion, hurtigere puls,
synsforstyrrelser eller problemer med koncentrationsevnen, skal De
indtage lidt sukker for at få blodsukkerniveauet til at stige igen. Tal
med lægen eller apotekspersonalet, hvis De er i tvivl om, hvordan De
genkender disse symptomer. Det anbefales, at De altid medbringer
sukkerknalder, slik, kiks eller sød frugtjuice.</p>
<p>Knoglebrud Der er set et øget antal knoglebrud hos patienter, særligt
kvinder, der tog pioglitazon. Deres læge vil tage dette i betragtning
ved planlægning af Deres behandling.</p>
<p>Børn og unge Børn og unge under 18 år må normalt ikke få
Competact.</p>
<p>Brug af anden medicin sammen med Competact Hvis du skal have sprøjtet
et kontrastmiddel, som indeholder jod, ind i dit blod, for eksempel i
forbindelse med en røntgenundersøgelse eller scanning, skal du stoppe
med at tage Competact forud for eller på tidspunktet for injektionen.
Lægen vil beslutte, hvornår du skal stoppe behandlingen med Competact,
og hvornår du kan genoptage den igen.</p>
<p>Fortæl det altid til lægen eller apotekspersonalet, hvis De bruger
anden medicin, for nylig har brugt anden medicin eller planlægger at
bruge anden medicin. Du skal eventuelt have kontrollere dit blodsukker
eller din nyrefunktion hyppigere, eller lægen kan ændre din dosis af
Competact. Det er især vigtigt, at du nævner følgende:</p>
<ul>
<li>gemfibrozil (bruges til at sænke kolesteroltallet)</li>
<li>rifampicin (bruges til behandling af tuberkulose og andre
infektioner)</li>
<li>cimetidin (bruges til behandling af for meget mavesyre)</li>
<li>glukokortikoider (bruges til behandling af vævsirritation)</li>
<li>beta-2-agonister (bruges til behandling af astma)</li>
<li>vanddrivende lægemidler (diuretika)</li>
<li>lægemidler mod smerter og betændelseslignende tilstande (NSAID’er og
COX-2-hæmmere, såsom ibuprofen og celecoxib)</li>
<li>visse lægemidler, der nedsætter blodtrykket
(angiotensinkonverterende enzym (ACE)-hæmmere og angiotensin
II-receptorantagonister)</li>
</ul>
<p>Brug af Competact sammen med alkohol Du skal undgå at indtage store
mængder alkohol, mens du er i behandling med Competact, da det kan øge
risikoen for laktatacidose (se afsnittet " Risiko for laktatacidose
").</p>
<p>Graviditet og amning</p>
<ul>
<li>Hvis De er gravid eller ammer, har mistanke om, at De er gravid,
eller planlægger at blive gravid, skal De fortælle det til Deres læge.
Det anbefales ikke at tage Competact under graviditet. Deres læge vil
råde Dem til at stoppe med at tage denne medicin., hvis De ønsker at
blive gravid.</li>
<li>Tag ikke Competact, hvis De ammer eller ønsker at amme (se afsnittet
"Tag ikke Competact").</li>
</ul>
<p>Trafik- og arbejdssikkerhed Dette lægemiddel vil ikke påvirke Deres
evne til at køre bil eller arbejde med maskiner. Vær forsigtig, hvis De
får synsforstyrrelser.</p>
<p>Competact indeholder natrium Dette lægemiddel indeholder mindre end 1
mmol (23 mg) natrium pr. tablet, dvs. det er i det væsentlige
natriumfrit.</p>
 </div>"""   
                    
* section[=].section[+]
  * title =  "3. Sådan skal du tage competact"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. Sådan skal du tage competact"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag altid dette lægemiddel nøjagtigt efter lægens eller
apotekspersonalets anvisning. Er De i tvivl, så spørg lægen eller på
apoteket.</p>
<p>Den anbefalede dosis er én tablet to gange daglig. Efter behov kan
Deres læge give Dem besked om at tage en anden dosis. De skal tage
tabletterne med et glas vand. Hvis du har nedsat nyrefunktion, kan din
læge eventuelt ordinere en lavere dosis, som eventuelt skal gives som
separate tabletter med pioglitazon og metformin.</p>
<p>De bør tage tabletterne i forbindelse med et måltid eller umiddelbart
efter et måltid for at nedsætte risikoen for maveproblemer.</p>
<p>Hvis De følger en speciel diabetesdiæt, skal De fortsætte med denne,
mens De tager Competact.</p>
<p>Deres vægt skal tjekkes med jævne mellemrum. Kontakt lægen, hvis
Deres vægt stiger.</p>
<p>Deres læge vil bede Dem om at få taget blodprøver periodevis, mens De
er i behandling med Competact. Dette sker for at kontrollere, at Deres
lever fungerer normalt. Mindst en gang om året (oftere, hvis De er en
ældre person eller har nyreproblemer) vil Deres læge kontrollere, at
Deres nyrer fungerer normalt.</p>
<p>Hvis De har taget for meget Competact<br />
Kontakt lægen, skadestuen eller apoteket, hvis De ved en fejltagelse har
taget for mange tabletter, eller hvis en anden eller et barn tager Deres
medicin. Blodsukkeret kan falde til under det normale niveau, men kan
bringes til at stige igen ved indtagelse af sukker. Det anbefales, at De
altid medbringer sukkerknalder, slik, kiks eller sød frugtjuice. Hvis De
har taget for mange Competact, kan De få laktacidose (se afsnittet
"Risiko for laktatacidose").</p>
<p>Hvis De har glemt at tage Competact Tag Competact dagligt som
foreskrevet. Hvis De glemmer en dosis, skal De imidlertid springe den
glemte dosis over og bare fortsætte med den næste dosis som normalt. De
må ikke tage en dobbeltdosis som erstatning for en glemt tablet.</p>
<p>Hvis De holder op med at tage Competact For at opnå den ønskede
virkning skal De tage Competact hver dag. Hvis De holder op med at tage
Competact, kan Deres blodsukker stige. Tal med lægen, før De stopper
behandlingen.</p>
<p>Spørg lægen eller apotekspersonalet, hvis der er noget, De er i tvivl
om.</p>
 </div>"""         

        
* section[=].section[+]
  * title = "4. Bivirkninger"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Bivirkninger"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som alle andre lægemidler give bivirkninger, men
ikke alle får bivirkninger.</p>
<p>Competact kan forårsage en meget sjælden (kan forekomme hos op til 1
ud af 10.000 brugere), men meget alvorlig bivirkning, der kaldes
laktatacidose (se afsnittet "Risiko for laktatacidose"). Hvis dette sker
for dig, skal du omgående stoppe med at tage Competact og kontakte læge
eller nærmeste hospital, da laktatacidose kan føre til koma.</p>
<p>Blærekræft forekommer med hyppigheden "ikke almindelig" (kan ramme op
til 1 ud af 100 behandlede) hos patienter, der tager Competact. Tegn og
symptomer omfatter blod i urinen, smerter ved vandladning eller en
pludselig vandladningstrang. Hvis De oplever nogen af disse symptomer,
skal De hurtigst muligt kontakte Deres læge.</p>
<p>Knoglebrud har været almindeligt forekommende (kan påvirke op til 1
ud af 10 behandlede) hos kvindelige patienter, der tager Competact, og
er ligeledes indberettet hos mandlige patienter (hyppighed kan ikke
vurderes ud fra de tilgængelige data). Kontakt hurtigst muligt Deres
læge, hvis De oplever denne bivirkning.</p>
<p>Uskarpt syn på grund af hævelser (eller væske) bagest i øjet
(makulaødem) (hyppigheden kan ikke vurderes ud fra tilgængelige data).
Hvis De oplever dette for første gang, skal De kontakte Deres læge så
hurtigt som muligt. De skal også kontakte Deres læge hurtigst muligt,
hvis De allerede har sløret syn, og symptomerne forværres.</p>
<p>Der er rapporteret om allergiske reaktioner med ukendt hyppighed
(hyppigheden kan ikke vurderes ud fra tilgængeligedata) hos patienter,
der tager Competact. Hvis du får en alvorlig allergisk reaktion,
herunder nældefeber og hævelse af ansigtet, læber, tunge eller svælg,
der kan forårsage vejrtræknings- eller synkebesvær, skal du afbryde
behandlingen og straks kontakte en læge.</p>
<p>Følgende bivirkninger er forekommet hos patienter, der tog
Competact</p>
<p>Meget almindelige (kan forekomme hos flere end 1 ud af 10
behandlede)</p>
<ul>
<li>mavesmerter</li>
<li>kvalme</li>
<li>opkastning</li>
<li>diarre</li>
<li>appetitløshed</li>
</ul>
<p>Almindelige (kan forekomme hos 1 ud af 10 behandlede)</p>
<ul>
<li>lokale hævelser (ødemer)</li>
<li>vægtstigning</li>
<li>hovedpine</li>
<li>infektion i luftvejene</li>
<li>synsforstyrrelser</li>
<li>ledsmerter</li>
<li>impotens</li>
<li>blod i urinen</li>
<li>blodmangel (anæmi)</li>
<li>følelsesløshed</li>
<li>smagsforstyrrelser</li>
</ul>
<p>Ikke almindelige(kan ramme op til 1 ud af 100 behandlede)</p>
<ul>
<li>bihulebetændelse</li>
<li>luft i maven</li>
<li>søvnløshed</li>
</ul>
<p>Meget sjældne(kan forekomme hos op til 1 ud af 10.000 brugere)</p>
<ul>
<li>nedsat indhold af cyanocobalamin (vitamin B12) i blodet</li>
<li>hudrødme</li>
<li>hudkløe</li>
<li>hævet og kløende udslæt (nældefeber)</li>
</ul>
<p>Ikke kendt (hyppigheden kan ikke vurderes ud fra
tilgængeligedata)</p>
<ul>
<li>leverbetændelse (hepatitis)</li>
<li>nedsat leverfunktion (ændringer i leverenzymværdier)</li>
</ul>
<p>Indberetning af bivirkninger Hvis De oplever bivirkninger, bør De
tale med Deres læge eller apotekspersonalet. Dette gælder også mulige
bivirkninger, som ikke er medtaget i denne indlægsseddel. De eller Deres
pårørende kan også indberette bivirkninger direkte til
Lægemiddelstyrelsen via det nationale rapporteringssystem anført i
Appendiks V. Ved at indrapportere bivirkninger kan De hjælpe med at
fremskaffe mere information om sikkerheden af dette lægemiddel.</p>
 </div>"""      
        
* section[=].section[+]
  * title = "5. Opbevaring"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. Opbevaring"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar lægemidlet utilgængeligt for børn.</p>
<p>Brug ikke lægemidlet efter den udløbsdato, der står på æsken og
blisterkortet. Udløbsdatoen (EXP) er den sidste dag i den nævnte
måned.</p>
<p>Dette lægemiddel kræver ingen særlige forholdsregler vedrørende
opbevaringen.</p>
<p>Spørg apotekspersonalet, hvordan De skal bortskaffe medicinrester. Af
hensyn til miljøet må De ikke smide medicinrester i afløbet, toilettet
eller skraldespanden.</p>
 </div>"""      
        
        
* section[=].section[+]
  * title = "6. Pakningsstørrelser og yderligere oplysninger"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Pakningsstørrelser og yderligere oplysninger"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Competact indeholder</p>
<ul>
<li>Aktive stoffer: pioglitazon og metforminhydrochlorid. Hver tablet
indeholder 15 mg pioglitazon (som hydrochlorid) og 850 mg
metforminhydrochlorid.</li>
<li>Øvrige indholdsstoffer: mikrokrystallinsk cellulose, povidon (K 30),
croscaramellosenatrium, magnesiumstearat, hypromellose, macrogol 8000,
talcum og titandioxid (E171).</li>
</ul>
<p>Udseende og pakningstørrelser De filmovertrukne tabletter
(tabletterne) er hvide til offwhite, aflange og konvekse mærket med ‘15
/ 850’ på den ene side og ‘4833M’ på den anden side.<br />
De leveres i aluminium/aluminium-blisterpakninger med 56 og 112
tabletter.</p>
<p>Ikke alle pakningsstørrelser markedsføres nødvendigvis.</p>
<p>Indehaver af markedsføringstilladelsen CHEPLAPHARM Arzneimittel GmbH
Ziegelhof 17489 Greifswald Tyskland</p>
<p>Fremstiller Takeda Ireland Limited, Bray Business Park, Kilruddery,
County Wicklow, Irland Delpharm Novara S.r.l., Via Crosa, 86, I-28065
Cerano (NO), Italien Lilly S.A., Avda. de la Industria 30, 28108
Alcobendas, Madrid, Spanien</p>
<p>Denne indlægsseddel blev senest ændret august 2023. Andre
informationskilder</p>
<p>De kan finde yderligere oplysninger om dette lægemiddel på Det
Europæiske Lægemiddelagenturs hjemmeside <a
href="http://www.ema.europa.eu/">http://www.ema.europa.eu/</a>.</p>
 </div>"""      





                    
Instance: bundlepackageleaflet-en-6717e3b12c817674be9c520895f4090e
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for competact Package Leaflet for language en"
Description: "ePI document Bundle for competact Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-6717e3b12c817674be9c520895f4090e"
* entry[0].resource = composition-en-6717e3b12c817674be9c520895f4090e

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp6717e3b12c817674be9c520895f4090e"
* entry[=].resource = mp6717e3b12c817674be9c520895f4090e
                            
                    
Instance: bundlepackageleaflet-da-6717e3b12c817674be9c520895f4090e
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for competact Package Leaflet for language da"
Description: "ePI document Bundle for competact Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-6717e3b12c817674be9c520895f4090e"
* entry[0].resource = composition-da-6717e3b12c817674be9c520895f4090e

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp6717e3b12c817674be9c520895f4090e"
* entry[=].resource = mp6717e3b12c817674be9c520895f4090e
                            
                    



Instance: mp6717e3b12c817674be9c520895f4090e
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Competact 15 mg/850 mg film-coated tablets"
Description: "Competact 15 mg/850 mg film-coated tablets"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/06/354/005"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Competact 15 mg/850 mg film-coated tablets"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: 6717e3b12c817674be9c520895f4090eListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "competact"

* status = #current
* mode = #working

* title = "List of all ePIs associated with competact"

* subject = Reference(mp6717e3b12c817674be9c520895f4090e)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#competact "competact"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-6717e3b12c817674be9c520895f4090e) // competact en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-6717e3b12c817674be9c520895f4090e) // competact da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-6717e3b12c817674be9c520895f4090e
InstanceOf: List
Description: "ePI document List for competact Package Leaflets"

* insert 6717e3b12c817674be9c520895f4090eListRuleset
    